{{Rsnum
|rsid=1860661
|Chromosome=19
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=TCF3
|position=1650135
|Gene_s=TCF3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.1 | 46.9 | 15.0
| HCB | 0.7 | 20.4 | 78.8
| JPT | 0.0 | 13.3 | 86.7
| YRI | 0.0 | 19.7 | 80.3
| ASW | 0.0 | 29.8 | 70.2
| CHB | 0.7 | 20.4 | 78.8
| CHD | 0.0 | 23.9 | 76.1
| GIH | 5.9 | 41.6 | 52.5
| LWK | 0.9 | 17.3 | 81.8
| MEX | 19.0 | 34.5 | 46.6
| MKK | 1.9 | 33.3 | 64.7
| TSI | 36.3 | 46.1 | 17.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=24920014
|Title=A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}